Alto Neuroscience Inc

ANRONASDAQ · US

Holders

ACQUIREDT+7
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
+55,000 sh · $127.6K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
+56,455 sh · $132.7K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
−886 sh · $23.8K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
−110,830 sh · $2.9M
Filed 1 Oct 2026SEC Form 4view source
ACQUIREDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
+54,375 sh · $127.8K
Filed 1 Oct 2026SEC Form 4view source
ACQUIREDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
+24,056 sh · $56.5K
Filed 1 Oct 2026SEC Form 4view source
REDUCEDT+30
Smith Nicholas Conrad
Alto Neuroscience Inc · NASDAQ
−23,170 sh · $597.3K
Filed 1 Oct 2026SEC Form 4view source
DISCLOSEDStale
Renaissance Technologies
Alto Neuroscience Inc · NASDAQ
103,499 sh · $2.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Alto Neuroscience Inc · NASDAQ
216,099 sh · $4.9M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Alto Neuroscience Inc · NASDAQ
16,613 sh · $373.5K
Filed 31 Mar 2026SEC 13Fview source